I. Vachier (Montpellier, France)
Establishment of a post-discharge virtual ward to optimise care for copd patients following admission to hospital.
M. Hardinge (Oxford (Oxfordshire), United Kingdom), J. Riley (Oxford (Oxfordshire), United Kingdom), C. Swindale (Oxford (Oxfordshire), United Kingdom), A. Ovington (Oxford (Oxfordshire), United Kingdom), A. Robinson (Oxford (Oxfordshire), United Kingdom), K. Kearley (Oxford (Oxfordshire), United Kingdom)
|   |
Roles of PI3k pan-inhibitors and PI3k-d inhibitors in allergic lung inflammation: systematic review and a meta-analysis
Y. Lee (Jeonju, Republic of Korea), J. Kim (Jeonju, Republic of Korea), J. Jeong (Jeonju, Republic of Korea), S. Kwon (Jeonju, Republic of Korea), S. Kim (Jeonju, Republic of Korea)
| |
Type 2 inflammation-related comorbidities among patients with asthma, chronic rhinosinusitis with nasal polyps, and atopic dermatitis
A. Khan (Chilly-Mazarin, France), I. Gouia (Chilly-Mazarin, France), S. Kamat (Tarrytown, United States of America), B. Ortiz (Tarrytown, United States of America), R. Johnson (Bridgewater, United States of America), J. Siddall (Bollington, United Kingdom), M. Small (Bollington, United Kingdom)
| |
Effect of Dupilumab on patient-reported breathing and rescue medication use
J. Corren (Los Angeles, United States of America), M. Castro (Kansas City, United States of America), J. Maspero (Buenos Aires, Argentina), W. Busse (Madison, United States of America), A. Valero Santiago (Barcelona, Spain), P. Kuna (Lodz, Poland), N. Daizadeh (Cambridge, United States of America), N. Pandit-Abid (Bridgewater, United States of America), B. Ortiz (Tarrytown, United States of America), A. Khan (Chilly-Mazarin, France), S. Kamat (Tarrytown, United States of America)
| |
Effect of dupilumab on severe exacerbations and lung function in patients with baseline blood eosinophils =500 cells/µL
K. Rabe (Grosshansdorf, Germany), I. Pavord (Oxford, United Kingdom), M. Castro (Kansas City, United Kingdom), N. Daizadeh (Cambridge, United States of America), B. Ortiz (Tarrytown, United States of America), R. Johnson (Bridgewater, United States of America), Y. Deniz (Tarrytown, United States of America), P. Rowe (Bridgewater, United States of America)
| |
Real-world adherence of subcutaneous (SCIT) and sublingual (SLIT) pollen AIT: A retrospective analysis in Germany
C. Vogelberg (Dresden, Germany), B. Brueggenjuergen (Berlin, Germany), H. Richter (Frankfurt, Germany), M. Jutel (Wroclaw, Poland)
| |
House dust mite sublingual immunotherapy reduces type 2 biomarkers in allergic asthma
M. Hoshino (Atami, Japan), K. Akitsu (Atami, Japan), K. Kubota (Atami, Japan), J. Ohtawa (Atami, Japan)
| |
The effect of specific Hymenoptera VIT using the ultra-rush method on immunoregulatory properties of T and B Lymphocytes, histamine, tryptase and serum cytokine concentrations.
L. Szymanski (Warsaw, Poland), A. Zakrzewski (Warsaw, Poland), M. Ciepielak (Warsaw, Poland), A. Cios (Warsaw, Poland), W. Urbanska (Warsaw, Poland), J. Kruszewski (Warsaw, Poland), W. Stankiewicz (Warsaw, Poland), A. Chcialowski (Warsaw, Poland)
| |
Pharmacodynamic effects of nebulised bronchodilator combinations
I. Shishimorov (Volgograd, Russian Federation), O. Magnitskaya (Volgograd, Russian Federation), O. Fadina (Volgograd, Russian Federation), E. Belan (Volgograd, Russian Federation), N. Maliuzhinskaia (Volgograd, Russian Federation)
| |
Patterns of atopy and allergic-respiratory outcomes in older adults
D. Bui (Melbourne (VIC), Australia), C. Lodge (Melbourne (VIC), Australia), J. Perret (Melbourne (VIC), Australia), A. Lowe (Melbourne (VIC), Australia), M. Abramson (Melbourne, Australia), G. Hamilton (Melbourne, Australia), B. Erbas (Melbourne, Australia), H. Walters (Melbourne (VIC), Australia), S. Dharmage (Melbourne (VIC), Australia)
| |
Clinico-radiological and serological features in Allergic bronchopulmonary aspergillosis.
P. P (Amritsar (Punjab), India)
| |
Allergy in patients with lymphangioleiomyomatosis
E. Radzikowska (Warszawa, Poland), J. Nowacka-Ejsmont (Suwalki, Poland), J. Milkowska-Dymanowska (Lodz, Poland), E. Wiatr (Warsaw, Poland), K. Blasinska (Warsaw, Poland), A. Rozy (Warsaw, Poland), M. Pujana (Barcelona, Spain)
| |
Allergy testing in asthmatics and severe asthmatics: habits among respiratory physicians in Belgium
B. Flahou (Amsterdam, Netherlands), J. Van Schoor (Vilvoorde, Belgium), S. Vancayzeele (Vilvoorde, Belgium), S. Gurdain (Vilvoorde, Belgium)
| |
Impact of subcutaneous allergoid AIT on patients with allergic rhinitis and/or asthma: A retrospective real-life, long-term cohort analysis
C. Vogelberg (Dresden, Germany), B. Brueggenjuergen (Berlin, Germany), H. Richter (Frankfurt, Germany), M. Jutel (Wroclaw, Poland)
| |
The impact of obesity in patients with severe asthma in the Wessex Severe Asthma Cohort (WSAC)
L. Fox (Portsmouth, United Kingdom), T. Brown (Portsmouth, United Kingdom), L. Wiffen (Portsmouth, United Kingdom), T. Jones (Portsmouth, United Kingdom), K. Gove (Southampton, United Kingdom), C. Barber (Southampton, United Kingdom), S. Elliott (Portsmouth, United Kingdom), H. Rupani (Portsmouth, United Kingdom), A. Chauhan (Portsmouth, United Kingdom), P. Howarth (Southampton, United Kingdom)
| |
Allergy and respiratory infections in Nigerian university athletes: a cross-sectional study
O. Awopeju (Ile-Ife (Osun State), Nigeria), A. Arawomo (Ile-Ife (Osun State), Nigeria), G. Erhabor (Ile-Ife (Osun State), Nigeria)
| |
Features of apoptosis, formation of membrane-released microparticles in case of lymphocyte damage in young patients with bronchial asthma, depending on body mass index
I. Soloveva (Krasnoyarsk (Krasnoyarsk), Russian Federation), I. Demko (Krasnoyarsk (Krasnoyarsk), Russian Federation), E. Sobko (Krasnoyarsk (Krasnoyarsk), Russian Federation), A. Kraposhina (Krasnoyarsk (Krasnoyarsk), Russian Federation), N. Gordeeva (Krasnoyarsk (Krasnoyarsk), Russian Federation), D. Anikin (Krasnoyarsk (Krasnoyarsk), Russian Federation)
| |
Latent classes of adults with persistent asthma: data from the multicentre INSPIRERS studies
R. Amaral (Porto, Portugal), C. Jácome (Porto, Portugal), R. Almeida (Porto, Portugal), A. Pereira (Porto, Portugal), C. Chaves Loureiro (Coimbra, Portugal), C. Lopes (Porto, Portugal), A. Mendes (Lisboa, Portugal), J. Cidrais-Rodrigues (Matosinhos, Portugal), J. Carvalho (Matosinhos, Portugal), A. Arrobas (Coimbra, Portugal), A. Todo Bom (Coimbra, Portugal), C. Ribeiro (Coimbra, Portugal), J. Azevedo (Leiria, Portugal), P. Leiria Pinto (Lisboa, Portugal), N. Neuparth (Lisboa, Portugal), F. Todo-Bom (Loures, Portugal), A. Costa (Guimarães, Portugal), C. Lozoya (Castelo Branco, Portugal), N. Santos (Portimão, Portugal), D. Silva (Porto, Portugal), L. Taborda-Barata (Covilhã, Portugal), R. Rodrigues-Alves (Ponta Delgada, Portugal), A. Moreira (Ponta Delgada, Portugal), C. Pinto (Vila Real, Portugal), P. Morais Silva (Portimão, Portugal), C. Alves (Barreiro, Portugal), R. Câmara (Barreiro, Portugal), D. Bordalo (V. N. Famalicão, Portugal), R. Fernandes (Lisboa, Portugal), R. Ferreira (Lisboa, Portugal), J. Ferraz De Oliveira (Alfena, Portugal), F. Menezes (Almada, Portugal), R. Gomes (Almada, Portugal), M. Cálix (Viseu, Portugal), J. Cardoso (Lisboa, Portugal), C. Nunes (Portimão, Portugal), R. Câmara (Funchal, Portugal), J. Ferreira (V. N. Gaia, Portugal), M. Ferreira-Magalhães (Porto, Portugal), C. Vidal ( Santiago de Compostela, Spain), S. López Freire ( Santiago de Compostela, Spain), P. Méndez Brea ( Santiago de Compostela, Spain), D. Antolín-Amérigo (Madrid, Spain), B. De La Hoz Caballer (Madrid, Spain), A. Barra Castro (Madrid, Spain), D. Gonzalez-De-Olano (Madrid, Spain), J. A. Fonseca (Porto, Portugal)
| |
Effects of MACVIA-ARIA Sentinel Network for Allergic Rhinitis (MASK-Air) Mobile Phone Application on Asthma Control in Patients with Asthma
M. Gencer (Manisa, Turkey), Y. Havlucu (Manisa, Turkey), D. Kizilirmak (Manisa, Turkey), A. Yorgancioglu (Manisa, Turkey), B. Gemicioglu (Istanbul, Turkey), J. Bousquet (Montpellier, France)
| |